Pioneering digital cytometry.
Accelerating biomarker discovery.
iSort™ delivers cell-type composition and cell-type specific gene expression
— at the click of a button.
iSort™ replaces tissue dissociation, antibody panel design, and fluorescent compensation with a single bulk RNA-seq analysis.
Our ProductsUnlocking new potential in life sciences research with the best-in-class AI powered digital cytometry platform.
Developed by Stanford professors and industry experts, iSort ™ is the first commercially available, industry grade software platform that extracts cell type–resolved insights from complex biological samples using bulk RNA-seq data, an accurate, high throughput, low-cost alternative to other methods to determine cell type composition.
Our technologyFor a broad range of applications:
- Tumor Microenvironmental Profiling
- Biomarker Discovery
- Blood Profiling
- Companion Diagnostics
- Normal Tissue Development
Across a diverse range of disease areas and conditions:
- Cancer
- Autoimmune Disease
- Transplantation
- Infertility
Trusted by leading pharmaceutical companies, diagnostic companies, academic researchers, and university medical centers.
A new standard in cellular profiling.
Run a free trial of iSort™ to experience accurate, robust, and simple AI-powered digital cytometry.
Built by a team of seasoned experts.
Brought together by a shared vision and a commitment to scientific excellence, the CiberMed leadership team is a cross-disciplinary group of veterans in their fields, including Stanford professors and physicians, bioinformatics and data science experts, and seasoned biotech entrepreneurs.
Our Team
Latest from CiberMed
